Medical devices, healthcare technology and the business of care
510(k) clearance · K262779

ANTHEM Fracture System

GLOBUS MEDICAL, INC. · Decision date Oct 23, 2026

MEDTECHLEDGER EXPLANATIONK262779

What did the FDA decide?

Globus Medical, Inc. received a substantially equivalent (SESE) decision for the ANTHEM™ Fracture System under 510(k) K262779, with a decision date of October 23, 2026 and a receipt date of August 5, 2026. The submission is a traditional 510(k) reviewed by FDA rather than a third party, classified under 21 CFR 888.3030 (bone fixation plate) with primary product code HRS and subsequent code HWC, in the orthopedic specialty. SESE is a clearance finding, not premarket approval.

The 510(k) summary describes the submission as a line extension covering ANTHEM® Large Fragment plates, Periprosthetic plates, and screws added to the existing ANTHEM™ Fracture System, which comprises plates, screws, and washers for internal bone fixation in titanium alloy, stainless steel, or cobalt chromium molybdenum alloy. The summary lists the ANTHEM™ Fracture System (K213591) as primary predicate with additional predicates including K163361, K202496, K100111, K120772, K210205, K203405, K082807, K092609, and K001709. Performance support was engineering analysis of static torsion, driving torque, and axial pullout for screws; no clinical outcome data are reported in the provided excerpts.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Oct 23, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262779
Regulatory pathway
510(k) premarket notification
Product code
HRS
Decision code
SESE
Decision date
Oct 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Plate, Fixation, Bone.

Product code
HRS
FDA device class
2

FDA decision timeline

  1. K262779 received

    Application receipt date recorded by FDA.

  2. K262779 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code HRS

Product / regulatory recordCompanyPathwayDecision dateSource
Hero Orthopedics, LLC510(k) clearanceNov 2, 2026FDA
ARTHREX, INC.510(k) clearanceOct 29, 2026FDA
Skeletal Dynamics, Inc.510(k) clearanceOct 26, 2026FDA
Pace Surgical510(k) clearanceOct 23, 2026FDA
Tdm Co., Ltd.510(k) clearanceOct 15, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

GLOBUS MEDICAL, INC.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Audubon, PA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records